Current status of drug screening and disease modelling in human pluripotent stem cells
The emphasis in human pluripotent stem cell (hPSC) technologies has shifted from cell therapy to in vitro disease modelling and drug screening. This review examines why this shift has occurred, and how current technological limitations might be overcome to fully realise the potential of hPSCs. Detai...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley-VCH Verlag
2013
|
| Online Access: | http://eprints.nottingham.ac.uk/2665/ http://eprints.nottingham.ac.uk/2665/ http://eprints.nottingham.ac.uk/2665/ http://eprints.nottingham.ac.uk/2665/1/Denning_Current_status_of_drug_screening.pdf |